1Kumar A, Kalra B, Patel A, et al. Development of a second generation anti-Mullerian hormone e(AMH)ELISA [J].J Immunat Methods, 2010,362 ( 1 - 2) :51-59.
3Tomasz W, Magdalena OG1, Jerzy C, et al. Anti-Mullerian hormone and fertility disturbances in obese women and women with polycystic ovary syndrome [J]. Ginekol Pol,2011,82 ( 3 ) : 205-209.
5Van Disseldorp J, Lambalk C B, Kwee J, et al. Comparison of inter and intra cycle variability of anti M llerian hormone and antral follicle counts [J ]. Hum Reprod, 2010, 25(1) : 221- 227.
7Nardo L G, Gelbaya T A, Wilkinson H, et al. Circulating basal anti- Mullerian hormone levels as predictor of ovarian response in women undergoing ovarian stimulation for in vitro fertilization [J]. Fertil Steril, 2009,92(5) : 1586-1593.
8Knauff E A, Eijkemans M J, Lambalk C B, et al . AntiMu llerian hormone, inhibin B, and antral follicle countin young women with ovarian failure [J]. J Clin Endocrinol Metab, 2009, 94: 786-792.
9Sowers M, McConnell D, Gast K, et al. Anti-Mullerian hormone and nhibin B variability during normal menstrual cycles [J]. Fertil Steril,2010,94 (4) : 1482-1486.
10Nardo L G, Gelbaya T A, Tarek A, et al. Circulating basal antiMti lllerian hor mone levels asp redict or of ovarian res ponse in women undergoing ovarian stimulation for in vitro fertilizati on [J]. Fertil Steril, 2009, 92(5) : 1586-1593.
2Tarlatzis BC,Zepiridis L,Grimbizis,G et al.Clinical management of low ovarian response to stimulation for IVF[J].Hum Reprod Update,2003,9:61.
3Eman A,Elgindy A,Dahlia O,et al.Anti-Mullerian hormone:correlation of early follicular,ovulatory and midluteal levels with ovarian response and cycle outcome in intracytoplasmic sperm injection patients[J].Fertil Steril,2008,89 (6):1670-1676.
4Ubaldi FM,Rienzi L,Ferrero S,et al.Management of poor responders in IVF[J].Reprod Biomed Online,2005,10(3):235-246.
5Nakhuda GS,Chu MC,Wang JG,et al.Elevated serum mullerian-inhibiting substance may be a marker for ovarian hyperstimulation syndrome in normalwomen undergoing in vitro fertilizationfertilization[J].Fertil Steril,2006,85:1541-1543.
6Chang MY,Chiang CH,Hsieh TT,et al.Use of the antral follicle count to predict the outcome of assisted reproductive technologies[J].Fertil Steril,1998,69(3):505-510.
7Hendriks DJ,Mol BW,Bancsi FJ,et al.Antral follicle count in the prediction of poor ovarian response and pregnancy after invit fertilization:a meta analysis and comparision with basal follicle stimulating hormone level[J].Fertil Steril,2005,83 (2):291-301.
8Catteau-Jonard S, Pigny P,Reyss AC,et al. Changes in serum anti-Mullerian hormone level during low-dose recombinant follicular-stimulating hormone therapy for anovulation in polycystic ovary syndrome [ J ]. J Clin Endocrinol Metab ,2007 ,92 :4138-4143.
9Streuli I, Fraisse T, Pillet C, et al. Serum anti-Mtillerian hormone levels remain stable throughout the menstrual cycle and after oral or vaginal administration of synthetic sex steroids [J].Fertil Steril, 2008,90 : 395-400.
10carlsson IB, Scott JE, Visser JA,et al. Anti-Mullerian hormone inhibits initiation of growth of human primordial ovarian follicles in vitro [ J ]. Hum Reprod, 2006,21 : 2223- 2227.
7La Marca A, Broekmans FJ, Volpe A. Anti-Mullerian hormone (AMI-I) : what do we still need to know? [J]. Hum Repred, 2009,24 (9) : 2264-2275.
8Chang H J, Han SH, Lee JR, et al. Impact of laparoscopic cystectomy on ovarian reserve: serial changes of serum anti- Mullerian hormone levels [ J ]. Fertil Steril, 2010,94 ( 1 ) : 343 - 349.
9Iwase A, Hirokawa W, Goto M, et al. Serum anti-Mullerian hormone level is a useful marker for evaluating the impact of laparoscopic cystectomy on ovarian reserve [ J ]. Fertil Steril, 2010,94(9) : 2846-2849.
10Cela V, Fresehi L, Simi G, et al. Fertility and endocrine outcome after robotassisted laparoscopic myomectomy (RALM) [ J ]. Gynecol Endocrinol, 2013,29 ( 1 ) : 79-82.
